News

The Los Angeles County Department of Public Health received notice from the U.S. Centers for Disease Control and Prevention ...
The Centers for Disease Control and Prevention's vaccine advisory committee is set to meet for the first time since Health ...
Merck's Enflonsia vaccine for respiratory syncytial virus won approval from the Centers for Disease Control and Prevention's ...
The CDC's Advisory Committee on Immunization Practices (ACIP) has issued new vaccine recommendations affecting RSV and flu ...
At the first meeting of a controversial new group of vaccine advisers to the US Centers for Disease Control and Prevention, ...
Enflonsia is an extended half-life RSV fusion glycoprotein neutralizing monoclonal antibody that is designed to provide durable protection through 5 months.
An outside group of experts agreed that the CDC should recommend a new antibody drug that offers protection against RSV for ...
State workers who for decades have been pivotal in identifying U.S. cancer trends, curbing new cases, and improving screening ...
News about Centers for Disease Control and Prevention, including commentary and archival articles published in The New York Times.
The Centers for Disease Control and Prevention's vaccine advisory committee is set to meet for the first time since Health ...